BMRN
Biomarin Pharmaceutical Inc
Price:  
64.86 
USD
Volume:  
1,039,844.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin Stock Forecast & Price Target

Biomarin Stock Price Forecast

The average stock forecast for Biomarin Pharmaceutical Inc (BMRN) in the next 12 months is 98.91 USD. This price target corresponds to an upside of 52.50%. The range of stock forecasts for Biomarin is 65.65 - 133.35 USD. Based on the ratings of 35 analysts, the consensus recommendation for Biomarin is BUY.
Target Low Average Median High
Price (USD) 65.65 98.91 96.39 133.35
Upside 1.22% 52.50% 48.61% 105.60%

Recommendation Trends

The latest consensus rating for Biomarin is "BUY". This is the average recommendation of 35 analysts: 0 strong sell, 0 sell, 8 hold, 16 buy, 11 strong buy. In the previous period, 35 analysts also majorly recommmended "BUY" for Biomarin.

Biomarin Financial Stock Forecast

Revenue This Year
2.88B
18.88%
from 2.42B
Revenue Next Year
3.17B
10.12%
from 2.88B
EPS This Year
2.11
139.83%
from 0.88
EPS Next Year
3.13
48.20%
from 2.11